Iwasa Takeshi, Amiya Eisuke, Ando Jiro, Watanabe Masafumi, Murasawa Takahide, Komuro Issei
Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of General Internal Medicine, Oncologic Emergencies, National Cancer Center Hospital, Tokyo, Japan.
PLoS One. 2016 Aug 10;11(8):e0160632. doi: 10.1371/journal.pone.0160632. eCollection 2016.
We compared the contribution of physical activity to the change in arterial stiffness between patients with and without diabetes in ischemic heart disease.
We studied 96 (diabetes) and 109 (without diabetes) patients with ischemic heart disease treated by percutaneous coronary intervention (PCI). Arterial stiffness was assessed by cardio-ankle vascular index (CAVI) at the first diagnosis of significant coronary ischemia and 6 months after PCI and optimal medical therapy. Physical activity was evaluated using the long form of the International Physical Activity Questionnaire (IPAQ).
CAVI values increased more for diabetic patients than for non-diabetic. The IPAQ scores did not differ between the two groups. During follow-up, CAVI values did not significantly change in either group. In diabetic patients, the CAVI score for 48 patients did not change (NC-group) and 48 patients improved (Improved-group). Physical activity scores were 937.9 ± 923.2 and 1524.6 ± 1166.2 in the NC- and Improved-groups, respectively. IPAQ scores and uric acid levels significantly affect CAVI improvement after adjusting for age, sex, baseline CAVI, total cholesterol, and estimated glomerular filtration rate.
Determining factors influencing CAVI improvement during follow-up were significantly different between patients with and without diabetes. IPAQ scores and uric acid levels were significantly correlated with CAVI changes.
我们比较了有糖尿病和无糖尿病的缺血性心脏病患者中身体活动对动脉僵硬度变化的影响。
我们研究了96例(糖尿病患者)和109例(非糖尿病患者)接受经皮冠状动脉介入治疗(PCI)的缺血性心脏病患者。在首次诊断为严重冠状动脉缺血时以及PCI和最佳药物治疗6个月后,通过心踝血管指数(CAVI)评估动脉僵硬度。使用国际体力活动问卷(IPAQ)长表评估身体活动情况。
糖尿病患者的CAVI值升高幅度大于非糖尿病患者。两组间IPAQ评分无差异。随访期间,两组的CAVI值均无显著变化。在糖尿病患者中,48例患者的CAVI评分未改变(NC组),48例患者有所改善(改善组)。NC组和改善组的身体活动评分分别为937.9±923.2和1524.6±1166.2。在调整年龄、性别、基线CAVI、总胆固醇和估计肾小球滤过率后,IPAQ评分和尿酸水平显著影响CAVI的改善。
有糖尿病和无糖尿病患者在随访期间影响CAVI改善的决定因素存在显著差异。IPAQ评分和尿酸水平与CAVI变化显著相关。